Showing results (21-30 of 116) with videos related to
Sort By:
Pageof 12
Cancer Science|November 4, 2014
Intermittent chemotherapy can retain the therapeutic potential of anti-CD137 antibody during the late tumor-bearing stateMiki Tongu, Nanae Harashima, Koji Tamada, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2002
Signaling through NK cell-associated CD137 promotes both helper function for CD8+ cytolytic T cells and responsiveness to IL-2 but not cytolytic activityRyan A Wilcox, Koji Tamada, Scott E Strome, et al.The Journal of Experimental Medicine|April 17, 2002
Ligand binding sites of inducible costimulator and high avidity mutants with improved functionShengdian Wang, Gefeng Zhu, Koji Tamada, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 primingRobert Vassallo, Koji Tamada, Julie S Lau, et al.Plos One|May 15, 2014
Involvement of IL-18 in the expansion of unique hepatic T cells with unconventional cytokine profiles during Schistosoma mansoni infectionKeishi Adachi, Risa Nakamura, Yoshio Osada, et al.Molecular Cancer Therapeutics|October 22, 2021
Enhanced Antitumor Responses of Tumor Antigen-Specific TCR T Cells Genetically Engineered to Produce IL7 and CCL19Yoshihiro Tokunaga, Takahiro Sasaki, Shunsuke Goto, et al.Nature Biotechnology|March 6, 2018
IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumorKeishi Adachi, Yosuke Kano, Tomohiko Nagai, et al.Oncoimmunology|May 3, 2014
Eomesodermin is required for antitumor immunity mediated by 4-1BB-agonist immunotherapyChang Song, Kavitha Sadashivaiah, Aki Furusawa, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2013
Soluble CD80 restores T cell activation and overcomes tumor cell programmed death ligand 1-mediated immune suppressionSamuel T Haile, Sonia P Dalal, Virginia Clements, et al.The Journal of Allergy and Clinical Immunology|February 15, 2015
Tumor necrosis factor superfamily 14 (LIGHT) controls thymic stromal lymphopoietin to drive pulmonary fibrosisRana Herro, Ricardo Da Silva Antunes, Amelia Roman Aguilera, et al.Pageof 12